| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | T. Ban | |
| G. Kato | |||
| P2860 | cites work | Brain receptors for antipsychotic drugs and dopamine: direct binding assays | Q24619577 |
| Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency | Q28260144 | ||
| Decreased cardiac beta-adrenoceptors in hypertensive rats | Q28322233 | ||
| Alterations of brain neurotransmitter receptor binding in Huntington's chorea | Q31152135 | ||
| Tricyclic antidepressant drugs block histamine H2 receptor in brain | Q34122901 | ||
| Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs | Q34192438 | ||
| Barbiturate receptor sites are coupled to benzodiazepine receptors | Q34252358 | ||
| Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain | Q34363450 | ||
| Antipsychotic drug doses and neuroleptic/dopamine receptors | Q34455159 | ||
| EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. | Q34540614 | ||
| Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism | Q34696629 | ||
| The impact of peptide hormone receptor research on clinical medicine | Q37804348 | ||
| Demonstration of specific high affinity binding sites for [3H] imipramine in human brain | Q71274216 | ||
| High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine | Q71416544 | ||
| beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system | Q72418442 | ||
| Differential effects of antidepressant treatment on brain monoaminergic receptors | Q72418560 | ||
| The Dopamine Radioreceptor Assay-A Clinical Application | Q72440248 | ||
| The inability of chronic mianserin to block central α2-adrenoceptors | Q72456270 | ||
| High-affinity bindingof [3H]mianserin to rat cerebral cortex | Q72456293 | ||
| Dopamine receptors, neuroleptics, and schizophrenia | Q72461206 | ||
| Rapid desensitization of cerebral cortical beta-adrenergic receptors induced by desmethylimipramine and phenoxybenzamine | Q72849187 | ||
| Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue | Q72851843 | ||
| Molecular heterogeneity of benzodiazepine receptors | Q72859968 | ||
| Effect of age on adrenergic and dopaminergic receptor binding in rat brain | Q72863271 | ||
| Ethanol enhances [3H]diazepam binding at the benzodiazepine-GABA-receptor-ionophore complex | Q72878941 | ||
| Drugs, neurotransmitters, and schizophrenia | Q81035575 | ||
| Antidepressants and the Muscarinic Acetylcholine Receptor | Q39139113 | ||
| Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain | Q39169821 | ||
| Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding | Q39178164 | ||
| Tricyclic antidepressants block histamine H1 receptors of mouse neuroblastoma cells | Q39197698 | ||
| Reduced diazepam binding following chronic benzodiazepine treatment | Q39219456 | ||
| Antagonism of central histamine H1 receptors by antipsychotic drugs | Q39226601 | ||
| Dopaminergic supersensitivity after neuroleptics: Time-course and specificity | Q39229865 | ||
| A Rapid and Sensitive Radioreceptor Assay for Benzodiazepine in Plasma | Q39231702 | ||
| The "neuroleptic" antipsychotic drugs. 1. Mechanisms of action | Q39240476 | ||
| Relationship between benzodiazepine receptors and experimental anxiety in rats | Q39240687 | ||
| Alterations in the benzodiazepine receptor of Huntington's diseased human brain | Q39242585 | ||
| No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam | Q39244283 | ||
| Effect of aging on neurotransmitter receptor binding in rat and human brain | Q39244298 | ||
| Differential enhancement of locomotor activity by dopamine agonists following chronic neuroleptic treatment: an animal model of tardive dyskinesia | Q39247536 | ||
| β 1 - and β 2 -Adrenergic Receptors in Rat Cerebral Cortex Are Independently Regulated | Q39250102 | ||
| Decreased 3H-diazepam binding is a specific response to chronic benzodiazepine treatment | Q39253614 | ||
| Increased specific binding of [H]diazepam in rat brain following chronic diazepam administration | Q39256122 | ||
| Benzodiazepine receptors: Cellular and behavioral characteristics | Q39277933 | ||
| Tricyclic antidepressants: Potent blockade of histamine H1 receptors of guinea pig ileum | Q39287214 | ||
| Minireview: Histamine receptors in brain | Q39289045 | ||
| Relationship of the Actions of Neuroleptic Drugs to the Pathophysiology of Tardive Dyskinesia | Q39300277 | ||
| Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations | Q39307732 | ||
| Increased dopamine-receptor sensitivity in schizophrenia | Q39498162 | ||
| Alterations in dopaminergic receptors in Huntington's disease | Q39832325 | ||
| Characterization of brain dopaminergic receptors in Huntington's disease | Q39858412 | ||
| Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines | Q40027308 | ||
| Receptors for the Age of Anxiety: Pharmacology of the Benzodiazepines | Q40081698 | ||
| Chronic neuroleptic treatment and dopamine receptor regulation | Q40082675 | ||
| Reduced β-adrenergic receptor concentrations in ageing man | Q40093721 | ||
| Development of β-adrenergic receptor subsensitivity by antidepressants | Q40093742 | ||
| Alterations in 3H-GABA binding in Huntington's chorea | Q40100876 | ||
| Blockade of presynaptic ?-receptors and of amine uptake in the rat brain by the antidepressant mianserine | Q40119600 | ||
| Tricyclic Antidepressants: Therapeutic Properties and Affinity for α-Noradrenergic Receptor Binding Sites in the Brain | Q40120503 | ||
| Receptor Adaptations to Centrally Acting Drugs | Q40124746 | ||
| Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors | Q40130681 | ||
| Functional Aspects of the Norepinephrine Receptor Coupled Adenylate Cyclase System in the Limbic Forebrain and its Modification by Drugs which Precipitate or Alleviate Depression: Molecular Approaches to an Understanding of Affective Disorders | Q40137145 | ||
| β-Adrenergic Receptors in Aged Rat Brain: Reduced Number and Capacity of Pineal Gland to Develop Supersensitivity | Q40154817 | ||
| The Benzodiazepine Receptor in Normal and Pathological Human Brain | Q40177295 | ||
| The effect of imipramine and lithium on α- and β-receptor binding in rat brain | Q40188494 | ||
| Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex | Q40195870 | ||
| Pre- and postsynaptic neurochemical alterations in Alzheimer's disease | Q40196582 | ||
| Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment | Q40225614 | ||
| Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine | Q40239409 | ||
| Electroconvulsive treatment: rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down regulation of beta-adrenergic receptors | Q40266327 | ||
| Lithium effects on adrenergic receptor supersensitivity in rat brain | Q40266644 | ||
| Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline | Q40604538 | ||
| Elevation of brain neuroleptic/dopamine receptors in schizophrenia | Q41530785 | ||
| Heterogeneity of histamine H1-receptors: species variations in [3H]mepyramine binding of brain membranes | Q41634685 | ||
| Specific tricyclic antidepressant binding sites in rat brain | Q41752061 | ||
| The pharmacology of tardive dyskinesias | Q42438225 | ||
| Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain | Q42438675 | ||
| Increased in vivo binding of 3H-Pimozide in mouse striatum following repeated administration of haloperidol | Q43530296 | ||
| Brain specific benzodiazepine receptors | Q44452528 | ||
| Brain histamine receptors as targets for antidepressant drugs | Q44587875 | ||
| Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors | Q45157485 | ||
| Benzodiazepine receptors in rat brain | Q45205253 | ||
| Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea | Q45300694 | ||
| Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study | Q45300896 | ||
| Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia | Q45300939 | ||
| Biochemical abnormalities in Huntington's chorea brains | Q45302938 | ||
| Benzodiazepine receptors: the effect of GABA on their characteristics in human brain and their alteration in Huntington's disease | Q45303601 | ||
| Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months | Q48097951 | ||
| Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains | Q48166703 | ||
| Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity | Q48174762 | ||
| 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus | Q48189651 | ||
| Serotonergic component of neuroleptic receptors | Q48203921 | ||
| Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains | Q48244288 | ||
| Benzodiazepine receptor: demonstration in the central nervous system | Q48250292 | ||
| A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood | Q48251559 | ||
| The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states | Q48427090 | ||
| D-LSD binding to brain homogenates: Possible relationship to serotonin receptors | Q48499078 | ||
| INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS. | Q51264563 | ||
| Pentobarbital: Dual Actions to Increase Brain Benzodiazepine Receptor Affinity | Q51868472 | ||
| Pentobarbital potentiates GABA-enhanced [3H]-diazepam binding to benzodiazepine receptors. | Q51875371 | ||
| Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. | Q52720658 | ||
| Tricyclic antidepressant radioreceptor assay | Q60447004 | ||
| Schizophrenia | Q66702663 | ||
| Modifications of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants | Q66959805 | ||
| Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine | Q67297981 | ||
| A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patients | Q70730735 | ||
| Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain | Q70802980 | ||
| Does high affinity [3H] imipramine binding label serotonin reuptake sites in brain and platelet? | Q70883101 | ||
| Radioreceptor assay for benzodiazepines in biological fluids using a new dry and stable receptor preparation | Q71016990 | ||
| Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding | Q71182815 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 207-222 | |
| P577 | publication date | 1982-01-01 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Central nervous system receptors in neuropsychiatric disorders | |
| P478 | volume | 6 |
Search more.